Tag: the-committee
-
U.S. Senate panel postpones Mylan hearing
The U.S. Senate Judiciary Committee on Monday postponed a hearing planned for next week to discuss Mylan NV's pending $465 million settlement to resolve charges that it underpaid government healthcare programs by misclassifying its EpiPen emergency allergy treatment. Mylan, the Justice Department and the Centers for Medicare and Medicaid Services had all declined to send…
-
U.S. lawmakers press Mylan on EpiPen price increases
Two senior lawmakers on the U.S. Senate’s Judiciary Committee on Monday pushed for information regarding sharp price increases for EpiPens, drug-filled injectable devices used by people to counter potentially deadly allergic reactions. Senator Chuck Grassley, chairman of the Senate Judiciary Committee, wrote Mylan Chief Executive Heather Bresch on Monday to ask how Mylan determined the…
-
Pfizer boosts cancer drug roster with $14 billion Medivation deal
Medivation shares jumped nearly 20 percent to close at $80.42, just shy of the offer price of $81.50 per share. Shares of Pfizer, the largest U.S. drugmaker, were down 0.4 percent at $34.84. The offer is a 55-percent premium to Sanofi SA's initial bid to buy Medivation for $52.50 per share in April, which pushed…
-
Shkreli plans to remain silent at congressional hearing: letter
Former drug executive Martin Shkreli plans to assert his right against self-incrimination and remain silent if he is forced to appear at a congressional hearing in Washington next week about drug prices, according to a letter seen by Reuters. Shkreli's lawyer informed the U.S. House Committee on Oversight and Government Reform of his intent not…